V Square Quantitative Management LLC purchased a new stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) in the first quarter, Holdings Channel reports. The firm purchased 274 shares of the biopharmaceutical company’s stock, valued at approximately $225,000. A number of other hedge funds and other institutional investors also recently added to or […]
BNC Wealth Management LLC purchased a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 2,554 shares of the biopharmaceutical company’s stock, valued at approximately $2,099,000. A number of other institutional investors […]
AustralianSuper Pty Ltd boosted its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 1.2% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 118,019 shares of the biopharmaceutical company’s stock after buying an additional 1,424 shares during the quarter. AustralianSuper Pty Ltd’s holdings in Regeneron Pharmaceuticals were worth $96,973,000 as […]
Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its price target cut by Wells Fargo & Company from $915.00 to $875.00 in a research report sent to investors on Wednesday, The Fly reports. REGN has been the topic of several other research reports. Truist Financial lifted their price target on shares of Regeneron Pharmaceuticals from $856.00 […]
Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its price target decreased by Wells Fargo & Company from $915.00 to $875.00 in a report issued on Wednesday, The Fly reports. Other equities analysts have also issued research reports about the company. Raymond James raised Regeneron Pharmaceuticals from an underperform rating to a market perform rating in […]